ArticleFEBS open bio2026
Differential regulation of ZFAS1 splice variants by endoplasmic reticulum stress in hepatocyte cell lines.
Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The suppression of the long noncoding RNA (lncRNA) TRIBAL in hepatocytes was recently shown to affect the expression of pivotal regulators and hundreds of poorly understood or uncharacterized transcripts. The most upregulated transcript corresponded to a predicted splice variant of the lncRNA ZFAS1. Here, we characterize and investigate the role and regulation of ZFAS1 splice variants in liver cell models. New ZFAS1 splice variants were identified, all of which were enriched in the cytoplasm of HepG2 cells. TRIBAL suppression strongly upregulated a low-abundance ZFAS1 variant in hepatocytes but not in hepatoma models. However, preventing the upregulation of the ZFAS1 splice variant did not mitigate the impact of TRIBAL suppression in hepatocytes. ZFAS1 variants were rapidly but differentially increased in response to thapsigargin, which causes endoplasmic reticulum (ER) stress and activates the unfolded protein response (UPR). Inhibition of PERK, a central sensor of the UPR, had contrasting impacts on ZFAS1 variants in response to thapsigargin. Moreover, whereas the upregulation of the main ZFAS1 form was reduced by the suppression of the UPR mediators ATF4 and NFE2L2 (also known as NRF2), the other variants were not. Lastly, ZFAS1 suppression decreased cell viability both at baseline and in response to acute thapsigargin treatment. This work identifies novel ZFAS1 variants and uncovers a link between ER stress and ZFAS1 through the UPR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.